X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Continuous Manufacturing is Improving Biopharma Production

    AI in Drug Commercialization Market to Grow CAGR 24% by 2032

    Continuous Bioprocessing Market to Surge by 2028

    Advancing Asia-Pacific Healthcare & Biopharma Innovation

    Generative AI in Pharma: Opportunities & Challenges

    Global Biopharma Market to Hit $566B by 2032

    AI Boosts Small Molecule Therapies for I&I Diseases

    Celonic Group Signs Long-Term Multi-Year Manufacturing Service Agreement with LINDIS Biotech for the Commercial Supply of Catumaxomab

    Novartis bolsters late-stage cardiovascular pipeline with agreement to acquire Anthos Therapeutics for USD 925 million upfront

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Continuous Manufacturing is Improving Biopharma Production

    AI in Drug Commercialization Market to Grow CAGR 24% by 2032

    Continuous Bioprocessing Market to Surge by 2028

    Advancing Asia-Pacific Healthcare & Biopharma Innovation

    Generative AI in Pharma: Opportunities & Challenges

    Global Biopharma Market to Hit $566B by 2032

    AI Boosts Small Molecule Therapies for I&I Diseases

    Celonic Group Signs Long-Term Multi-Year Manufacturing Service Agreement with LINDIS Biotech for the Commercial Supply of Catumaxomab

    Novartis bolsters late-stage cardiovascular pipeline with agreement to acquire Anthos Therapeutics for USD 925 million upfront

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Drug Development Research & Development

Streetwise Reports Examines How A Development Agreement for Permian Basin Acreage Would Eliminate Capex Budget

Yuvraj_pawp by Yuvraj_pawp
4th December 2017
in Research & Development

The letter of intent signed to develop this oil & gas company’s large acreage in the red-hot Permian Basin would not only eliminate the company’s capex budget, it could give the company a long-term cash flow stream.

Amazing Energy Oil & Gas Co. (OTCQX:AMAZ) holds rights to 70,000 contiguous acres in the prolific Permian Basin. Today it announced that it has entered into an agreement with JH Fossil Energy, LLC to “develop Amazing’s current holdings in Pecos County Texas, as well as to be acquired assets located elsewhere in Texas.”

The agreements will allow JH Energy an opportunity “to acquire a 50% interest in the rights to approximately 70,000 continuous acres in Pecos County, TX exploiting the Yates, Seven Rivers, Grayburg, Queen, San Andres, Wolfcamp, Woodford, Devonian & Ellenburger pay zones and 6,600 acres located elsewhere in Texas that Amazing is currently in the process of acquiring.”

Technical analyst Clive Maund of CliveMaund.com, wrote on Nov. 26 that “the company has acquired a large block of land in the Permian Basin in Texas at an extremely cheap price, which is adjacent…

Continue reading this article: Development Agreement for Permian Basin Acreage Would Eliminate Capex Budget

About Streetwise Reports
Streetwise Reports shares investment ideas in many sectors. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security.

Previous Post

Triphase Accelerator To Present Investigational New Drug Enabling Data For TRPH-222

Next Post

CAR-T: The Designer Tumor Therapy Frontier

Related Posts

Drug Development

Continuous Bioprocessing Market to Surge by 2028

7th March 2025
Insights

Advancing Asia-Pacific Healthcare & Biopharma Innovation

7th March 2025
Insights

Generative AI in Pharma: Opportunities & Challenges

7th March 2025
Drug Development

Global Biopharma Market to Hit $566B by 2032

7th March 2025
Clario joins forces with Mobilise-D to advance Digital Mobility Outcomes in clinical trials
News

Detect-ION and Moffitt Cancer Center Collaborate to Revolutionize Lung Cancer Early Detection

19th August 2024
News

Scaling Cell And Gene Therapies: Challenges And Solutions

11th August 2024
Next Post

CAR-T: The Designer Tumor Therapy Frontier

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In